LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.31623
 24.81 84.90 573 1769 0.3238 0.5462
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 26.51 84.90 615 1923 0.3198 0.5525
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 26.51 84.90 972 1923 0.5054 0.7187
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 26.51 84.90 159 1923 0.0827 0.1496
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 26.51 84.90 676 1923 0.3515 0.5855
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 28.21 84.90 686 2091 0.3280 0.5715
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 28.21 84.90 1009 2091 0.4824 0.7082
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 28.21 84.90 165 2091 0.0789 0.1546
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 28.21 84.90 617 2091 0.2950 0.5358
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 29.92 84.90 829 2237 0.3705 0.6206
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 29.92 84.90 1011 2237 0.4518 0.6902
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 29.92 84.90 202 2237 0.0903 0.2016
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 29.92 84.90 668 2237 0.2985 0.5481
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 31.62 84.90 883 2449 0.3605 0.6206
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 31.62 84.90 1057 2449 0.4315 0.6818
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 31.62 84.90 257 2449 0.1049 0.2565
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 31.62 84.90 791 2449 0.3229 0.5842
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 33.32 84.90 884 2722 0.3247 0.5973
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 33.32 84.90 1025 2722 0.3765 0.6453
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 33.32 84.90 241 2722 0.0885 0.2319
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 33.32 84.90 662 2722 0.2432 0.5076
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 35.03 84.90 928 2991 0.3102 0.5926
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 35.03 84.90 1030 2991 0.3443 0.6253
MN20160318_Q02
D08
MCF 10A-H2B-mCherry Trametinib
0.31623
 35.03 84.90 291 2991 0.0973 0.2709
MN20160318_Q02
M17
MCF 10A-H2B-mCherry Trametinib
0.31623
 35.03 84.90 715 2991 0.2390 0.5138
MN20160318_Q02
M17